Search

everythinglearnresearchcommunity

for

Search:↓

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

An elderly Chinese man lost all his hair after taking a new heart medication.

Some blood thinners can cause hair loss, but switching medications can stop it.

Early diagnosis and surgery are crucial for managing cryptorchidism and related hair loss in dogs.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Pentoxifylline helps hair regrowth in rats with hair loss.

A drug improved schizophrenia-like symptoms in stressed rats by changing brain steroid levels.

The new microneedle system improves hair growth in alopecia treatment.

A leukemia patient showed skin peeling similar to kwashiorkor, a severe protein deficiency.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Curcumin shows promise in reducing pain and inflammation, but more research is needed.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

Women using hair relaxers with alopecia had lower zinc levels, suggesting zinc deficiency might contribute to hair loss.

The document concludes that proper diagnosis and treatment of nonscarring alopecias can improve quality of life and hair regrowth is possible as the hair follicle remains intact.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

PRP therapy for alopecia shows inconsistent results due to natural variability in growth factor secretion by platelets.

Radiotherapy can cause skin fibrosis, which is often overlooked and needs better treatment and evaluation.

Low-Level Light Therapy is effective for skin rejuvenation, wound healing, and hair growth, with mild side effects.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.